Literature DB >> 28825979

Covalent coupling of high-affinity ligands to the surface of viral vector particles by protein trans-splicing mediates cell type-specific gene transfer.

Alexander Muik1, Johanna Reul1, Thorsten Friedel1, Anke Muth1, Karen Patricia Hartmann1, Irene C Schneider1, Robert C Münch1, Christian J Buchholz2.   

Abstract

We have established a novel approach for the covalent coupling of large polypeptides to the surface of fully assembled adeno-associated viral gene transfer vector (AAV) particles via split-intein mediated protein-trans-splicing (PTS). This way, we achieved selective gene transfer to distinct cell types. Single-chain variable fragments (scFvs) or designed ankyrin repeat proteins (DARPins), exhibiting high-affinity binding to cell surface receptors selectively expressed on the surface of target cells, were coupled to AAV particles harboring mutations in the capsid proteins which ablate natural receptor usage. Both, the AAV capsid protein VP2 and multiple separately produced targeting ligands recognizing Her2/neu, EpCAM, CD133 or CD30 were genetically fused with complementary split-intein domains. Optimized coupling conditions led to an effective conjugation of each targeting ligand to the universal AAV capsid and translated into specific gene transfer into target receptor-positive cell types in vitro and in vivo. Interestingly, PTS-based AAVs exhibited significantly less gene transfer into target receptor-negative cells than AAVs displaying the same targeting ligand but coupled genetically. Another important consequence of the PTS technology is the possibility to now display scFvs or other antibody-derived domain formats harboring disulfide-bonds in a functionally active form on the surface of AAV particles. Hence, the custom combination of a universal AAV vector particle and targeting ligands of various formats allows for an unprecedented flexibility in the generation of gene transfer vectors targeted to distinct cell types.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adeno-associated viral vector; Gene delivery; Receptor targeting; Split-intein

Mesh:

Substances:

Year:  2017        PMID: 28825979     DOI: 10.1016/j.biomaterials.2017.07.032

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  15 in total

Review 1.  Adeno-associated virus-based Alzheimer's disease mouse models and potential new therapeutic avenues.

Authors:  Lars M Ittner; Matthias Klugmann; Yazi D Ke
Journal:  Br J Pharmacol       Date:  2019-04-23       Impact factor: 8.739

2.  Programmable Assembly of Adeno-Associated Virus-Antibody Composites for Receptor-Mediated Gene Delivery.

Authors:  Alina C Zdechlik; Yungui He; Eric J Aird; Wendy R Gordon; Daniel Schmidt
Journal:  Bioconjug Chem       Date:  2019-12-20       Impact factor: 4.774

Review 3.  Precision medicine: In vivo CAR therapy as a showcase for receptor-targeted vector platforms.

Authors:  Alexander Michels; Naphang Ho; Christian J Buchholz
Journal:  Mol Ther       Date:  2022-05-20       Impact factor: 12.910

4.  CD30-targeted oncolytic viruses as novel therapeutic approach against classical Hodgkin lymphoma.

Authors:  Julia D S Hanauer; Benjamin Rengstl; Dina Kleinlützum; Johanna Reul; Anett Pfeiffer; Thorsten Friedel; Irene C Schneider; Sebastian Newrzela; Martin-Leo Hansmann; Christian J Buchholz; Alexander Muik
Journal:  Oncotarget       Date:  2018-01-12

5.  Tumor-Specific Delivery of Immune Checkpoint Inhibitors by Engineered AAV Vectors.

Authors:  Johanna Reul; Janina Frisch; Christine E Engeland; Frederic B Thalheimer; Jessica Hartmann; Guy Ungerechts; Christian J Buchholz
Journal:  Front Oncol       Date:  2019-02-14       Impact factor: 6.244

Review 6.  The lncRNA Connection Between Cellular Metabolism and Epigenetics in Trained Immunity.

Authors:  Ezio T Fok; Laurianne Davignon; Stephanie Fanucchi; Musa M Mhlanga
Journal:  Front Immunol       Date:  2019-01-29       Impact factor: 7.561

7.  GluA4-Targeted AAV Vectors Deliver Genes Selectively to Interneurons while Relying on the AAV Receptor for Entry.

Authors:  Jessica Hartmann; Frederic B Thalheimer; Felix Höpfner; Thomas Kerzel; Konstantin Khodosevich; Diego García-González; Hannah Monyer; Ilka Diester; Hildegard Büning; Jan E Carette; Pascal Fries; Christian J Buchholz
Journal:  Mol Ther Methods Clin Dev       Date:  2019-07-23       Impact factor: 6.698

8.  Membrane fusion FerA domains enhance adeno-associated virus vector transduction.

Authors:  Xintao Zhang; Bui Anthony; Zheng Chai; Amanda Lee Dobbins; Roger Bryan Sutton; Chengwen Li
Journal:  Biomaterials       Date:  2020-02-21       Impact factor: 12.479

Review 9.  New Routes and Opportunities for Modular Construction of Particulate Vaccines: Stick, Click, and Glue.

Authors:  Karl D Brune; Mark Howarth
Journal:  Front Immunol       Date:  2018-06-26       Impact factor: 7.561

10.  A Library-Based Screening Strategy for the Identification of DARPins as Ligands for Receptor-Targeted AAV and Lentiviral Vectors.

Authors:  Jessica Hartmann; Robert C Münch; Ruth-Therese Freiling; Irene C Schneider; Birgit Dreier; Washington Samukange; Joachim Koch; Markus A Seeger; Andreas Plückthun; Christian J Buchholz
Journal:  Mol Ther Methods Clin Dev       Date:  2018-07-06       Impact factor: 6.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.